Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Pal

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Chemistry & Biodiversity|July 26, 2024
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR-Targeted Anticancer AgentsKetan R Hosamani, Hemalatha K, Rohit Pal, et al.
European Journal of Medicinal Chemistry|June 13, 2024
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agentsB Kumaraswamy, K Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry|June 5, 2024
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationshipPronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Current Topics in Medicinal Chemistry|January 9, 2025
Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic BreakthroughsS Mounika, Hemalatha K, Rohit Pal, et al.
Frontiers in Chemistry|December 25, 2025
Exploring tetrazole chemistry: synthetic techniques, structure-activity relationship, and pharmacological insights in antimicrobial and anticancer therapyLalmohan Maji, Ghanshyam Teli, Rohit Pal, et al.
Bioorganic Chemistry|December 11, 2024
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insightMd Ashadul Sk, Hemalatha K, Gurubasavaraja Swamy Purawarga Matada, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 1, 2022
Bioprocessing of biowaste derived from food supply chain side-streams for extraction of value added bioproducts through biorefinery approachSivakumar Shri Vigneshwar, Authilingam Swetha, Kannappan Panchamoorthy Gopinath, et al.
European Journal of Medicinal Chemistry|September 10, 2024
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studiesAayishamma I, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Molecular Diversity|October 22, 2024
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationshipE Haripriya, K Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 10, 2025
In silico design, synthesis of a novel chalcone derivative and its in vitro and in vivo anticancer activity against colon cancer-induced mouse modelUday Raj Sharma, Sushavan Roy, Gurubasavaraja Swamy Purawargaar Matada, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Chemistry & Biodiversity|July 26, 2024
Pyrazole, Pyrazoline, and Fused Pyrazole Derivatives: New Horizons in EGFR-Targeted Anticancer AgentsKetan R Hosamani, Hemalatha K, Rohit Pal, et al.
European Journal of Medicinal Chemistry|June 13, 2024
An insight into sustainable and green chemistry approaches for the synthesis of quinoline derivatives as anticancer agentsB Kumaraswamy, K Hemalatha, Rohit Pal, et al.
European Journal of Medicinal Chemistry|June 5, 2024
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationshipPronoy Kanti Das, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Current Topics in Medicinal Chemistry|January 9, 2025
Benzimidazole Derivatives in Breast Cancer: Target-Specific Therapeutic BreakthroughsS Mounika, Hemalatha K, Rohit Pal, et al.
Frontiers in Chemistry|December 25, 2025
Exploring tetrazole chemistry: synthetic techniques, structure-activity relationship, and pharmacological insights in antimicrobial and anticancer therapyLalmohan Maji, Ghanshyam Teli, Rohit Pal, et al.
Bioorganic Chemistry|December 11, 2024
Current developments in PI3K-based anticancer agents: Designing strategies, biological activity, selectivity, structure-activity correlation, and docking insightMd Ashadul Sk, Hemalatha K, Gurubasavaraja Swamy Purawarga Matada, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|June 1, 2022
Bioprocessing of biowaste derived from food supply chain side-streams for extraction of value added bioproducts through biorefinery approachSivakumar Shri Vigneshwar, Authilingam Swetha, Kannappan Panchamoorthy Gopinath, et al.
European Journal of Medicinal Chemistry|September 10, 2024
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studiesAayishamma I, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
Molecular Diversity|October 22, 2024
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationshipE Haripriya, K Hemalatha, Gurubasavaraja Swamy Purawarga Matada, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 10, 2025
In silico design, synthesis of a novel chalcone derivative and its in vitro and in vivo anticancer activity against colon cancer-induced mouse modelUday Raj Sharma, Sushavan Roy, Gurubasavaraja Swamy Purawargaar Matada, et al.
Pageof 4